Personal reflections on the development of thrombolytic therapy and its application to acute coronary thrombosis

American Heart Journal

Volumn 102, Issue 6 PART 2, 1981, Pages 1134-1139

  Sherry, Sol ^a  

^a Temple University Health Sciences Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STREPTOKINASE; UROKINASE;

BLOOD AND HEMOPOIETIC SYSTEM; BLOOD CLOT LYSIS; CARDIOVASCULAR SYSTEM; CORONARY ARTERY THROMBOSIS; DRUG THERAPY; HEART; HEART INFARCTION; HUMAN CELL; METHODOLOGY; SHORT SURVEY; THERAPY;

CORONARY DISEASE; EMPYEMA; FIBRINOLYSIS; GERMANY, WEST; HEMOTHORAX; HISTORY OF MEDICINE, 20TH CENT.; HUMAN; PLASMIN; PLASMINOGEN; PULMONARY EMBOLISM; STREPTOKINASE; UNITED STATES; URINARY PLASMINOGEN ACTIVATOR;

EID: 0019818382     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/0002-8703(81)90643-8     Document Type: Article

References (31)

1. The fibrinolytic activity of hemolytic streptococci
2. A factor in normal human blood which participates in streptococcal fibrinolysis
3. A proteolytic enzyme of serum characterization activation and reaction with inhibitors
4. Nature and role of the lytic factor in hemolytic streptococcal fibrinolysis
5. The effect in patients of streptococcal fibrinolysin (streptokinase) and streptococcal desoxyribonuclease on fibrinous, purulent and sanguinous pleural exudations
6. The use of streptokinase-streptodornase in the treatment of hemothorax
7. The use of streptokinase-streptodornase in the treatment of postpneumonic empyema
8. The local use of streptokinase-streptodornase in chronic refractory areas of suppuration with draining sinuses
9. Lysis in rabbits of intravascular blood clots by the streptococcal fibrinolytic system (streptokinase)
10. The purification and crystallization of plasminogen (profibrinolysin)
11. Lysis of thrombi produced by sodium morrhuate in the femoral vein of dogs by human plasmin (fibrinolysin)
12. The activation of human plasminogen by streptokinase
13. The fibrinolytic activity of streptokinase-activated human plasmin
14. The enzymatic dissolution of experimental intravascular thrombi in the dog by trypsin chymotrypsin and plasminogen activators
15. Studies on enhanced fibrinolytic activity in man
16. Studies on the thrombolytic activity of human plasma
17. The mechanism of clot dissolution by plasmin
18. Pathogenesis of the coagulation defect developing during plasma proteolytic (“fibrinolytic”) states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products
19. The specific interaction between plasminogen and fibrin. A physiological role of the lysine binding site in plasminogen
20. The assay of thrombolytic (fibrinolytic) mixtures intended for therapeutic use
21. The lysis of artificially induced intravascular clots in man by intravenous infusions of streptokinase
22. The maintenance of a sustained thrombolytic state in man. I. Induction and effects
23. The maintenance of a sustained thrombolytic state in man. II. Clinical observations on patients with myocardial infarction and other thromboembolic disorders
24. The treatment of patients suffering from early myocardial infarction with massive and prolonged streptokinase therapy
25. Salvage of heart muscle by fibrinolytic therapy after experimental coronary occlusion
26. The development of urokinase as a thrombolytic agent. Maintenance of a sustained thrombolytic state in man by its intravneous infusion
27. Thrombolytic therapy with streptokinase using a standard dosage
28. The urokinase-pulmonary embolism trial Phase I results
29. Urokinase-streptokinase pulmonary embolism trial Phase II results
30. Streptokinase in acute myocardial infarction
31. Clinical experience with urokinase